Orphanion AG, a CRO/CMO that focuses on contract research and manufacturing services for niche active pharmaceutical ingredients (APIs), and LGM Pharma, a provider of API sourcing, warehousing and distribution services to the pharmaceutical and biotechnology industries, have finalized a partnering agreement. Under the terms of the agreement, Orphanion’s specialty services, such as production of difficult-to-synthesize molecules for niche applications, will be available to LGM Pharma clients.   “...